Japan IVD Raw Materials Market Size, Share & Trends Analysis Report By Product (Antibody, Antigens, Proteins, Enzymes, Biological Buffers, Substrates, Others), By Technology (Molecular Diagnostics, Clinical Chemistry, Immunochemistry, Others), By End User (Diagnostic Laboratories, Pharmaceutical & Biotechnological Companies, Others) and Forecasts, 2026-2034

Japan Ivd Raw Materials Market Size

The Japan IVD Raw Materials Market size was valued at USD 486 million in 2025 and is projected to grow from USD 530.23 million in 2026 to reach USD 1064.29 million by 2034, growing at a CAGR of 9.10% during the forecast period 2026–2034.

Japan's market is driven by the increasing prevalence of chronic diseases, a rapidly aging population, and strong government support for healthcare innovation. Additionally, the demand for advanced diagnostic technologies, such as molecular diagnostics and immunochemistry, is growing, further propelling market expansion.

Product Type Insights

Antibody dominates the product type segment and is expected to grow at a CAGR of 12.6% over the forecast period. Antibodies are the leading product type in Japan’s IVD raw materials market, primarily driven by the increasing use of immunoassays in cancer diagnostics and infectious disease testing. Monoclonal antibodies are particularly in demand for their precision in detecting biomarkers.

Request Customizationto receive a tailored report.

Technology Insights

Immunochemistry dominates the technology segment and is expected to grow at a CAGR of 13.1% over the forecast period. Molecular diagnostics is the fastest-growing technology segment in Japan. Adopting advanced diagnostic technologies like PCR and NGS for genetic testing and early disease detection drives this growth. Japan’s emphasis on precision medicine further accelerates the demand for raw materials for molecular diagnostics.

End User Insights

Pharmaceutical and biotechnological companies dominate the end-user segment and is expected to grow at a CAGR of 13.7% over the forecast period. Pharmaceutical and biotechnological companies account for a significant portion of the demand for IVD raw materials in Japan. These companies use raw materials for research, drug development, and clinical trials, particularly in oncology and infectious diseases.

Speak to an Analystto discuss market opportunities.

Japan Ivd Raw Materials Market Regional Insights

The market is characterized by diverse growth patterns across Japan’s major cities, driven by healthcare infrastructure, research capabilities, and demographic factors. The country’s well-established healthcare system, high investment in medical research, and increasing elderly population drive the market. Government support for diagnostic innovation and precision medicine further boosts the demand for IVD components, ensuring steady growth over the forecast period.

• Tokyo, as Japan’s capital and largest city, leads the IVD raw materials market, driven by its advanced healthcare infrastructure and concentration of research institutions. Tokyo’s hospitals and diagnostic centers are early adopters of molecular diagnostics and personalized medicine. The city accounted for nearly 30% of the IVD market in Japan in 2024, with steady growth expected due to ongoing investments in healthcare technology.
• Osaka, known for its vital pharmaceutical and biotech industries, significantly contributes to Japan’s IVD market. The city hosts some of Japan’s leading diagnostic firms and research institutions, making it a hub for innovation in diagnostic technologies. In 2024, Osaka’s IVD market grew by 9.8%, driven by demand for cancer diagnostics and molecular testing.
• Fukuoka is emerging as a key player in Japan’s IVD raw materials market due to its growing healthcare sector and increasing government investment in medical research. The city focuses on improving diagnostic services for its aging population. Fukuoka’s IVD market is expected to grow at a CAGR of 10.2% during the forecast period.
• Nagoya is known for its strong industrial base, but the city is also seeing growth in the healthcare and diagnostics sectors. The local government’s initiatives to improve healthcare access and diagnostics in rural areas have led to increased demand for IVD raw materials, particularly for infectious disease testing. Nagoya’s IVD market grew by 9.5% in 2024.
• Yokohama, located near Tokyo, benefits from its proximity to the capital’s advanced healthcare infrastructure. The city has seen a growing demand for diagnostic services, particularly in cardiovascular and genetic testing. The IVD market in Yokohama is forecasted to grow at a rate of 10.7% during the forecast period.
• Sapporo is witnessing increased investment in healthcare infrastructure, particularly in diagnostic services for the elderly population. The city’s healthcare system has been focusing on early detection of chronic diseases, which has driven the demand for IVD tests and raw materials. Sapporo’s IVD market grew by 8.9% in 2024; further growth is expected as healthcare services expand.

List of Key and Emerging Players in Japan IVD Raw Materials Market